Skip Navigation

Cardiovascular Research 1995 30(6):975-984; doi:10.1016/S0008-6363(95)00164-6
© 1995 by European Society of Cardiology
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bodi, I.
Right arrow Articles by Webster, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodi, I.
Right arrow Articles by Webster, K. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1995, European Society of Cardiology

Cell-specificity and signaling pathway of endothelin-1 gene regulation by hypoxia

Ilona Bodi, Nanette H. Bishopric, Daryl J. Discher, Xiaosu Wu and Keith A. Webster*

Molecular Cardiology Laboratory, Department of Cell and Molecular Biology, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA

* Corresponding author. Tel (415) 859 4417; Fax (415) 859-3342. cardiol{at}unix.sri.com

Objectives: Endothelin-1 (ET-1) is a potent vasoconstrictor that is expressed in endothelial cells and in many other cells and tissues. Increased plasma levels of the peptide have been associated with ischemic heart disease, atherosclerosis, and myocardial infarction. The objectives of the current study were (1) to determine the tissue specificity for induction of the ET-1 gene by hypoxia, (2) to determine whether the hypoxia regulatory pathway is the same as that in other hypoxia regulated genes and (3) to analyze the contributions of protein kinases for basal and induced expression of ET-1. Methods: ET-1 transcript levels were measured by Northern blot and quantitative polymerase chain reaction in endothelial and non-endothelial cells following exposure to hypoxia. Regulatory steps within the pathway were identified by treating aerobic or hypoxic cultures with cycloheximide, PMA, a series of selective protein kinase inhibitors, and transition metals. The effects on ET-1 transcripts were compared with the ubiquitous hypoxia inducible pyruvate kinase gene. Results: The induction of ET-1 by hypoxia in vitro occurred exclusively in early passage endothelial cells. This induction was prevented by treatment with the protein synthesis inhibitor cycloheximide and was at least partially mimicked by treatment with transition metals. Induction by hypoxia was not effected by inhibitors of protein kinase C, protein kinase A, calcium-calmodulin dependent protein kinase, or cyclic GMP dependent protein kinase. The basal expression was decreased and hypoxic induction was eliminated by treating cells with tyrosine kinase-selective inhibitors. Conclusions: Et-1 induction by hypoxia requires endothelial cell-specific factor(s) or steps, new protein synthesis, and may involve a haeme protein-containing pathway in oxygen sensing. A protein tyrosine kinase step is implicated for both basal and induced expression of the ET-1 gene.

KEYWORDS Signal transduction; Endotheiium; Endothelin-1; Cycloheximide; Transition metals; Gene expression; Hypoxia; Human umbilical arterial endothelial cells; Human umbilical venous endothelial cells; Tyrosine kinase


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. J. Allahdadi, T. W. Cherng, H. Pai, A. Q. Silva, B. R. Walker, L. D. Nelin, and N. L. Kanagy
Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H434 - H440.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
Z. Alioglu, A. Orem, I. Bulbul, C. Boz, M. Ozmenoglu, and B. Vanizor
Evaluation of Plasma Endothelin-1 Levels in Patients with Cerebral Infarction
Angiology, January 1, 2002; 53(1): 77 - 82.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
D. Lang, J. P Bell, U. Bayraktutan, G. R Small, A. M Shah, and M. J Lewis
Phenotypic changes in rat and guinea pig coronary microvascular endothelium after culture: loss of nitric oxide synthase activity
Cardiovasc Res, June 1, 1999; 42(3): 794 - 804.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Matsui, Y. Ihara, Y. Fujio, K. Kunisada, S. Akira, T. Kishimoto, and K. Yamauchi-Takihara
Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-{kappa}B and NF-IL6 in cardiac myocytes
Cardiovasc Res, April 1, 1999; 42(1): 104 - 112.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. Bayraktutan, Z.-K. Yang, and A. M Shah
Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat
Cardiovasc Res, June 1, 1998; 38(3): 719 - 726.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Prentice, N. H Bishopric, M. N Hicks, D. J Discher, X. Wu, A. A Wylie, and K. A Webster
Regulated expression of a foreign gene targeted to the ischaemic myocardium
Cardiovasc Res, September 1, 1997; 35(3): 567 - 574.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.